Last updated: October 25, 2023
Sponsor: Sohag University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Appendicitis
Treatment
Bilirubin level sodium level c reactive protein level
Clinical Study ID
NCT06102239
Soh-Med-23-09-08Ms
Ages 10-40 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- all patient admitted for acute appendicitis underwent surgery and post operativlyconfirmed histopathology of acute appendicitis
Exclusion
Exclusion Criteria:
- patient with liver disease Liver transplantation Chronic alcoholism Congental biliarydisease Pregnancy Appendicular neoplasm Hemolytic disease Hepatocellular carcinoma
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Bilirubin level sodium level c reactive protein level
Phase:
Study Start date:
October 01, 2023
Estimated Completion Date:
March 31, 2024
Connect with a study center
Sohag University hospital
Sohag,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.